Product Information
DARUNAVIR 800 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $2.2663 per EA under NDC 69097024402. Its NADAC has been published 119 times since Mar 20, 2024.
Strength
800 mg/1
Manufacturer
Cipla USA Inc.NDC
69097024402
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DARUNAVIR HYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA206288On Market Since
11/29/2023
Pharmacological Classes
Price Statistics
The NADAC for DARUNAVIR 800 MG TABLET has been published 119 times since Mar 20, 2024, and over the history we have for it it has declined 31.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2663 per EA |
|---|---|
| All-time high | $3.6749 (Oct 16, 2024) |
| All-time low | $2.1216 (Apr 22, 2026) |
| 52-week high | $2.5269 |
| 52-week low | $2.1216 |
| Median price | $2.5124 |
| Average price | $2.7332 |
| Largest weekly change | +25.3% (Aug 21, 2024) |
| Weeks tracked | 119 |
| Tracking since | Mar 20, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DARUNAVIR 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DARUNAVIR 800 MG TABLET, manufactured by Cipla USA Inc., is $2.2663 per EA (NDC 69097024402), effective Jun 24, 2026.
How has the price of DARUNAVIR 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for DARUNAVIR 800 MG TABLET has declined 31.7%. It has been tracked across 119 weekly CMS publications since Mar 20, 2024.
What are the highest and lowest recorded NADAC prices for DARUNAVIR 800 MG TABLET?
Since Mar 20, 2024, the NADAC for DARUNAVIR 800 MG TABLET has ranged from a low of $2.1216 (Apr 22, 2026) to a high of $3.6749 (Oct 16, 2024), with a median of $2.5124 per EA.
Are there cheaper alternatives to DARUNAVIR 800 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as DARUNAVIR 800 MG TABLET, but none are currently priced below it.
Who manufactures DARUNAVIR 800 MG TABLET?
DARUNAVIR 800 MG TABLET (NDC 69097024402) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification